BSEBoard Meeting4d ago · 12 Aug 2026, 01:30 pm
Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Clinitech Laboratory Ltd · 544220
✦ AI SummaryMgmt Change
Clinitech Laboratory Ltd has scheduled a board meeting on August 17, 2026, to consider and approve various matters, including the appointment of a director, the board's report for FY 2025-26, and the 16th Annual General Meeting.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Clinitech Laboratory Ltd - 544220 - Board Meeting Intimation for Board Meeting To Be Held On Monday, August 17, 2026 Through Video Conferencing At 11.30 A.M (IST).
Attachments (1)
📄pdf
Download →
44393de9-ac71-4ed2-8dfc-6395d34816a8.pdf
View document text
Date: August 12, 2026.
Asst. General Manager,
Dept. of Corporate Services,
BSE Limited
1st Floor, P.J. Towers,
Dalal Street, Fort,
Mumbai: 400001.
Sub: Intimation of Board Meeting.
Reference: CLINITECH LABORATORY LIMITED (CTLLAB) Scrip Code: 544220.
We wish to inform you that the meeting of the Board of Directors of the Company will be held on Monday,
August 17, 2026 through video conferencing at 11.30 A.M (IST):
To consider and approve appointment of director retiring by rotation;
To approve the Board’s report of the company along with all annexures thereof for the FY 2025-26;
To consider and approve notice convening 16th Annual General Meeting and the date, time & venue
thereof along with finalization of book closure dates;
To finalize the appointment of Mr. Deep Shukla, Practising Company Secretary as the scrutinizer to
oversee the voting process in a fair and transparent manner;
Any other matter with the permission of the Chair.
The above intimation is given to you pursuant to Regulation 29 and 30 of the SEBI (LODR) Regulations, 2015.
Thanking you,
Yours faithfully,
For CLINITECH LABORATORY LIMITED
Jagdish Umakant Nayak
Chairman and Managing Director
DIN: 00646672